A Potassium of 6.4 Five Days After an Antibiotic: Managing Hyperkalemia in a 74-Year-Old Man With Heart Failure on Lisinopril and Spironolactone, and Keeping the Drugs That Keep Him Alive
[Student Name]
University of Phoenix
NRP/556: Adult and Geriatric Management II
Week 1 Assignment
[Instructor Name]
[Date]
The patient is a composite written for a model paper.
Mr. F., a 74-year-old retired machinist, developed heart failure after a heart attack; his last echocardiogram put his ejection fraction at 30%. His regimen is lisinopril, spironolactone, carvedilol and a low dose of furosemide. Kidney function runs around an eGFR of 48, and his potassium usually sits near 4.8 mmol/L. Five days ago, urgent care prescribed trimethoprim-sulfamethoxazole for a urinary tract infection. Today he feels weak, and a routine lab drawn for another reason shows potassium 6.4 mmol/L and creatinine 1.9 mg/dL, up from 1.4. This paper describes what happened and what to do next.
The Immediate Priority
Potassium above 6.0 mmol/L with rising creatinine is dangerous because it can cause fatal arrhythmias. I call Mr. F., confirm he is weak but not short of breath or having palpitations and send him to the emergency department for an electrocardiogram and treatment: calcium to stabilize the heart muscle if the electrocardiogram shows changes, insulin with glucose and inhaled albuterol to shift potassium into cells and measures to remove potassium from the body. I tell him to stop the antibiotic, spironolactone and lisinopril until he is seen.
The Mechanism
Trimethoprim acts on the distal nephron like the potassium-sparing diuretic amiloride, blocking epithelial sodium channels and reducing potassium excretion. Spironolactone blocks aldosterone at the same segment, and lisinopril reduces aldosterone production. Three drugs acting on the same final pathway, in a man with reduced kidney function, produced a predictable result.
How Common Is This
In a population study of older adults on renin-angiotensin system blockers, Antoniou et al. (2010) found that trimethoprim-sulfamethoxazole was associated with a nearly sevenfold increase in the risk of hospitalization for hyperkalemia compared with amoxicillin, with no such risk for other antibiotics. The authors recommended alternative antibiotics for these patients when appropriate.
The antibiotic was reasonable for the infection and dangerous for the man; the prescriber at urgent care saw one and not the other.
A Lesson From RALES
Spironolactone became widely used in heart failure after a landmark trial showed reduced mortality. Juurlink et al. (2004) found that after that publication, spironolactone use rose steeply among older Ontario residents recently hospitalized for heart failure who were on ACE inhibitors, and so did hospitalizations for hyperkalemia, more than fourfold over seven years, with rising associated deaths. The authors called for closer laboratory monitoring and more careful use, a warning that applies to Mr. F.
Why the Drugs Still Matter
Spironolactone and lisinopril are not the problem to be removed; they are life-prolonging therapy. The 2022 heart failure guideline recommends a mineralocorticoid receptor antagonist for patients with heart failure with reduced ejection fraction when estimated glomerular filtration rate is above 30 mL/min/1.73 m² and potassium is below 5.0 mmol/L, with careful monitoring of potassium, kidney function and diuretic dosing (Heidenreich et al., 2022). The guideline also recommends renin-angiotensin system inhibition. Permanently stopping them would raise his risk of death and hospitalization.
After the Emergency
Mr. F. was treated in the emergency department and his potassium fell to 5.1 mmol/L. His urinary tract infection was switched to nitrofurantoin, appropriate given his kidney function. Two days later, his creatinine returned to 1.5 mg/dL.
Restarting Therapy
I plan a stepwise restart. Lisinopril is restarted first at 10 mg, with potassium and creatinine checked in one week. If potassium stays below 5.0 mmol/L, spironolactone is restarted at 12.5 mg daily, with labs at three days, one week and monthly for three months, following the guideline's emphasis on monitoring (Heidenreich et al., 2022). Potassium binders, which remove potassium through the gut, could allow continuation of these drugs if potassium runs high, and I will discuss them with cardiology if needed.
Preventing the Next Time
I add a prominent alert to Mr. F.'s chart and pharmacy profile: avoid trimethoprim-sulfamethoxazole, nonsteroidal anti-inflammatory drugs and potassium supplements or salt substitutes. I give him a wallet card listing his heart failure drugs and the drugs to avoid, and teach him to show it at any urgent care or emergency visit. I also call the urgent care clinic to share what happened.
Why the Kidney Function Fell
His creatinine climbed by about a third over baseline. Trimethoprim can raise creatinine by blocking its tubular secretion without changing true filtration, but his weakness and potassium suggest real kidney stress as well, possibly from the infection, reduced intake and the combined effects of his drugs. Rechecking creatinine after stopping the antibiotic separates the two: a rapid return to baseline, as happened, points toward the drug effect and reversible prerenal changes.
What the Electrocardiogram Can and Cannot Show
Peaked T waves, a widened QRS or loss of P waves signal cardiac toxicity from hyperkalemia and demand immediate treatment. A normal electrocardiogram, however, does not exclude danger; arrhythmias can occur without warning changes. This is why a potassium of 6.4 with a rising creatinine warranted emergency care even though he felt only weak.
Choosing an Antibiotic Next Time
For a urinary infection in a man taking these drugs, safer choices include nitrofurantoin when kidney function allows, a cephalosporin or a fluoroquinolone when appropriate, guided by culture results. The goal is to treat the infection without adding a drug that acts on the same potassium pathway.
Communicating Across Settings
Many adverse drug events happen when patients are seen in several places. Mr. F. did not mention his heart failure drugs at urgent care, and the prescriber did not ask. A shared electronic record, a current medication list in his wallet and a habit of calling his primary clinician after any new prescription would have prevented this episode.
The Role of Carvedilol and Furosemide
His beta blocker slightly impairs potassium shift into cells, and his loop diuretic helps excrete potassium. Neither caused the crisis, but both matter for the restart: keeping furosemide at an adequate dose supports potassium excretion, and the guideline notes that diuretic adjustment is part of managing potassium in patients on mineralocorticoid antagonists (Heidenreich et al., 2022).
Diet
I review his diet with a dietitian's handout. Potassium-rich foods need not be eliminated but should be moderate, and salt substitutes containing potassium chloride should be avoided.
Follow-Up Visit
One week after discharge, Mr. F. feels well, his potassium is 4.7 mmol/L on lisinopril alone and his weight and breathing are stable. We review the plan for spironolactone, schedule the laboratory checks around it and confirm that his wallet card is in his pocket, ready for any future visit.
Conclusion
Mr. F.'s hyperkalemia resulted from adding trimethoprim-sulfamethoxazole to lisinopril and spironolactone in a man with reduced kidney function, a combination that population data link to a sevenfold rise in hyperkalemia hospitalizations. After emergency treatment, the harder task is preserving his guideline-directed therapy, which reduces his risk of death, through a stepwise restart, close monitoring and safeguards against future interactions.
References
Antoniou, T., Gomes, T., Juurlink, D. N., Loutfy, M. R., Glazier, R. H., & Mamdani, M. M. (2010). Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: A population-based study. Archives of Internal Medicine, 170(12), 1045-1049. https://doi.org/10.1001/archinternmed.2010.142
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., . . . Yancy, C. W. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation, 145(18), e895-e1032. https://doi.org/10.1161/CIR.0000000000001063
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004). Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. New England Journal of Medicine, 351(6), 543-551. https://doi.org/10.1056/NEJMoa040135
How this NRP 556 Week 1 example is structured
The NRP/556 Week 1 work usually addresses complex cardiovascular conditions such as heart failure and atrial fibrillation. This paper handles an acute complication first, explains its mechanism and evidence, and then turns to the harder long-term question of preserving guideline-directed therapy in a patient at risk. Students search this week as NRP 556 Week 1, NRP556 Wk 1 or NRP/556 Wk 1; all three are the same assignment.
NRP/556 Week 1 questions, answered
What does NRP/556 Week 1 usually ask for?
Many sections present a complex cardiovascular case, such as heart failure or atrial fibrillation, and ask for management of complications and guideline-directed therapy.
Why does trimethoprim raise potassium?
Trimethoprim blocks sodium channels in the distal nephron, much like the diuretic amiloride, reducing potassium excretion. Combined with ACE inhibitors or mineralocorticoid antagonists, it can cause dangerous hyperkalemia.
Should spironolactone be stopped permanently after hyperkalemia?
Not necessarily. Mineralocorticoid antagonists reduce death in heart failure with reduced ejection fraction, so the goal is usually to correct the cause, monitor closely and restart when safe.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.